Aridis Pharmaceuticals, Inc.
ARDS·OTC Markets OTCPK·Healthcare
0.00020.0000 (0.00%)today
At close: Nov 3, 4:00 PM EST · May be delayed up to 15 min · USD
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Previous close0.0002
Open0.0015
Day range0.00020.0015
52-week range0.00010.0500
Off day high−86.21%
Off 52-week high−99.60%
Volume10.00
Avg. volume (3M)3.33K
Market cap8.91K
EPS (TTM)-0.3200
Forward P/E0.00
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)3,967.82
Shares outstanding44.57M
Short interest8.23% of float
Earnings dateJun 4, 2025 (est.)
Analyst target—
Profit margin−5.11%
Against its peers
Compare in full ›| ARDS | NIKI | 1952.HK | ACRS | CHRS | ZLAB | |
|---|---|---|---|---|---|---|
| Market cap | 8.91K | 5.27M | 9.83B | 570.34M | 131.36M | 2.83B |
| P/E (TTM) | — | — | — | — | — | — |
| Forward P/E | 0.0 | — | 20.4 | -5.1 | -1.3 | -10.9 |
| Price/book | 0.0 | 0.1 | 1.3 | 4.1 | 2.2 | 4.2 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | 0.00% | −87.43% | −44.53% | +62.11% | −42.95% | −11.45% |
| Today | 0.00% | −3.98% | +5.06% | −1.60% | +5.54% | +3.83% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All ARDS news ›Aridis Pharmaceuticals (ARDS) Projected to Post Quarterly Earnings on Monday
Posted by Defense World Staff on Oct 31st, 2026 Aridis Pharmaceuticals (NASDAQ:ARDS – Get Free Report) is projected to announce its resultson Monday, November 2nd. Analysts expect the company to announce earnings of ($0.5960) per share and…
More from 1 other outlet
From the 4Search news index, newest first.
In the news
2mentions in 30 days
2with it in the headline
Negativesentiment
Mentioned with
People in the coverage
Most coverage from
- defenseworld.net1
- themarketsdaily.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 2 articles, not a forecast.